Retrospective Cohort Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2149-2160
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2149
Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients
Elizabeth SL Low, Ross Apostolov, Darren Wong, Sandra Lin, Numan Kutaiba, Josephine A Grace, Marie Sinclair
Elizabeth SL Low, Ross Apostolov, Darren Wong, Josephine A Grace, Marie Sinclair, Department of Gastroenterology and Liver Transplant Unit, Austin Health, Heidelberg 3084, Victoria, Australia
Ross Apostolov, Josephine A Grace, Marie Sinclair, Department of Medicine, University of Melbourne, Melbourne 3000, Victoria, Australia
Sandra Lin, Department of Radiology, Monash Health, Clayton 3168, Victoria, Australia
Numan Kutaiba, Department of Radiology, Austin Health, Heidelberg 3084, Victoria, Australia
Author contributions: Low ES, Apostolov R, Lin S and Kutaiba N directly designed and performed the study, with contribution from Sinclair M, Wong D and Grace J; Low ESL, Lin S and Wong D collated and analysed the data; Low ESL wrote the paper, with revisions and editing by all other listed authors.
Institutional review board statement: This study was approved by the Austin Health Research Ethics Committee (ID 19/114) and carried out in line with the National Statement on Ethical Conduct in Human Research (2007).
Informed consent statement: All study participants or their legal guardian provided informed written consent about personal and medical data collection prior to study enrolment.
Conflict-of-interest statement: The authors declare no conflicts of interest or financial supports.
Data sharing statement: Patient consent was not obtained but the presented data are anonymised and risk of identification is low. No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Elizabeth SL Low, MBBS, Doctor, Department of Gastroenterology and Liver Transplant Unit, Austin Health, 145 Studley Road, Heidelberg 3084, Victoria, Australia. elizabeth_low312@hotmail.com
Received: April 16, 2021
Peer-review started: April 16, 2021
First decision: June 27, 2021
Revised: July 13, 2021
Accepted: September 19, 2021
Article in press: September 19, 2021
Published online: December 15, 2021
ARTICLE HIGHLIGHTS
Research background

Hepatocellular carcinoma (HCC) surveillance rates reported from the United States and Europe remain low, despite published clinical guideline recommendations. Surveillance patterns in Australia, which has the benefit a universal healthcare program, have not been clearly delineated.

Research motivation

Patients, and evaluate factors associated with greater uptake of HCC cancer screening. In incorporating both frequency of screening and quantity of imaging performed, we aimed to have a more continuous way of standardising ‘adherence’. Identification of determinants associated with higher HCC screening adherence aims to guide further areas for intervention.

Research objectives

As stated above, the objectives were characterising continuous HCC surveillance adherence. This method provides a way of standardising ‘adherence’, and thus allows for equal comparison between different studies evaluating the concept of HCC screening adherence.

Research methods

This was a retrospective cohort study that incorporated data electronic medical records to obtain patient demographics, clinical history, lab investigations and radiological imaging results. Data analysis was both on the univariate and multivariate level. In particular, quantile regression was performed for the non-parametric outcome variable, and provides greater description of covariate associations across the range of the outcome variable.

Research results

Follow-up of 775 at-risk patients demonstrated that median time-up-to-date with HCC surveillance was 84.2%. However, different patient factors, affected HCC surveillance adherence variably across different ranges of the outcome variable percentage of time up-to-date with HCC surveillance (PTUDS). At the 25th quantile/percentile for PTUDS, older age was associated with greater HCC surveillance. At the 50th quantile, African ethnicity had lower HCC surveillance. At the 75th quantile, cirrhotic status was associated with greater adherence to surveillance. Those of culturally and linguistically diverse backgrounds had lower continuous HCC surveillance rates at both the 50th and 75th quantiles. The ramifications of these findings and identified determinants affecting HCC surveillance participation in other settings, including the primary care setting, are less clear. However, they remain very important areas for further research. In particular, addressing the impact of ethnicity and cultural and linguistic backgrounds on screening uptake may well have beneficial consequent effects in other areas of healthcare.

Research conclusions

The study suggests specific patient and systemic factors that contribute to participation in HCC surveillance. These factors include younger age, non-cirrhotic status, African ethnicity and coming from a culturally and linguistically diverse background, which all are variably associated with lower percentage of time up-to-date with HCC surveillance.

Research perspectives

Future research should be directed at determining interventions aimed at the factors identified in this study to be associated with reduced HCC screening adherence. Those that improve participation in HCC surveillance may well benefit from widespread implementation to improve earlier diagnosis of HCCs.